Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin after intravenous and intramuscular administration in beagle dogs

References

• Albarellos GA, Kreil VE, Landoni MF. (2005). Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats. J Vet Pharmacol Ther 27:155–62
   Web of Science ®Google Scholar
• Aliabadi FS, Ali BH, Landoni MF, Lees P. (2003). Pharmacokinetics and PK-PD modeling of danofloxacin in camel serum and tissue cage fluids. Vet J 165:104–18
   PubMed Web of Science ®Google Scholar
• Aliabadi FS, Lees P. (2002). Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudates and transudate. J Vet Pharmacol Ther 25:161–74
   PubMed Web of Science ®Google Scholar
• Andes D, Craig WA. (2002). Animal model pharmacokinetics and phamacodynamics: a critical review. Int J Antimicrob Ag 19:261–8
   PubMed Web of Science ®Google Scholar
• Awji EG, Tassew DD, Lee JS, et al. (2012). Comparative mutant prevention concentration and mechanism of resistance to veterinary fluoroquinolones in Staphylococcus pseudintermedius. Vet dermatol 23:376–80
   PubMed Web of Science ®Google Scholar
• Carretero M, Rodrıguez C, San Andres MI, et al. (2002). Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration. Equine Vet J 34:360–5
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. (2007). Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement, M100-S17, Vol. 27 No. 1
   Google Scholar
• Craig WA. (1998). Pharmacokinetic/Pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26:1–10
   PubMed Web of Science ®Google Scholar
• Ding H, Li Y, Chen Z, et al. (2010). Plasma and tissue cage fluid pharmacokinetics of marbofloxacin after intravenous, intramuscular, and oral single-dose application in pigs. J Vet Pharmacol Ther 33:507–10
   PubMed Web of Science ®Google Scholar
• Elias G, Lee JS, Hwang MH, et al. (2009). Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of orbifloxacin in Korean Hanwoo cattle. J Vet Pharmacol Ther 32:219–28
   PubMed Web of Science ®Google Scholar
• Forrest A, Nix DE, Ballow CH, et al. (1993). Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 37:1073–81
   PubMed Web of Science ®Google Scholar
• Gloede J, Scheerans C, Derendorf H, Kloft C. (2010). In vitro pharmacodynamic models to determine the effect of antibacterial drugs. J Antimicrob Chemother 65:186–201
   PubMed Web of Science ®Google Scholar
• Heinen E. (2002). Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration. J Vet Pharmacol Ther 25:1–5
   PubMed Web of Science ®Google Scholar
• Horspool LJ, van Laar P, van den Bos R, Mawhinney I. (2004). Treatment of canine pyoderma with ibafloxacin and marbofloxacin: fluoroquinolones with different pharmacokinetic profiles. J Vet Pharmacol Ther 27:147–53
   PubMed Web of Science ®Google Scholar
• Ismail M, El-Kattan YA. (2007). Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves. Res Vet Sci 82:398–404
   PubMed Web of Science ®Google Scholar
• Kadlec K, Schwarz S, Perreten V, et al. (2010). Molecular analysis of methicillin-resistant Staphylococcus pseudintermedius of feline origin from different European countries and North America. J Antimicrob Chemother 65:1826–8
   PubMed Web of Science ®Google Scholar
• Klepser ME, Ernst EJ, Petzold CR, et al. (2001). Comparative bactericidal activities of ciprofloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumonia in a dynamic in vitro model. Antimicrob Agents Chemother 45:673–8
   PubMed Web of Science ®Google Scholar
• Larajeet R, Talmi A, Bounaga R, et al. (2006). Comparative pharmacokinetics of marbofloxacin after a single intramuscular administration at two dosages to camels (Camelus dromedaries). J Vet Pharmacol Ther 29:229–31
   PubMed Web of Science ®Google Scholar
• Madaras-Kelly KJ, Demasters TA. (2000). In vitro characterization of fluoroquinolone concentration/MIC antimicrobial activity and resistance while simulating clinical pharmacokinetics of levofloxacin, ofloxacin, or ciprofloxacin against Streptococcus pneumoniae. Diagn Microbiol Infect Dis 37:253–60
   PubMed Web of Science ®Google Scholar
• Marín P, Alamo LF, Escudero E, et al. (2013). Pharmacokinetics of marbofloxacin in rabbit after intravenous, intramuscular, and subcutaneous administration. Res Vet Sci 94:698–700
   PubMed Web of Science ®Google Scholar
• Meunier D, Acar JF, Martel JL, et al. (2004). A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets. Int J Antimicrob Agents 24:592–8
   PubMed Web of Science ®Google Scholar
• Nix DE, Matthias KR, Ferguson EC. (2004). Effect of ertapenem protein binding on killing of bacteria. Antimicrob Agents Chemother 48:3419–24
   PubMed Web of Science ®Google Scholar
• Perreten V, Kadlec K, Schwarz S, et al. (2010). Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother 65:1145–54
   PubMed Web of Science ®Google Scholar
• Schneider M, Valle M, Woehrle F, Boisrame B. (2004). Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains. J Dairy Sci 87:202–11
   PubMed Web of Science ®Google Scholar
• Sidhu PK, Landoni MF, Aliabadi FS, Lees P. PK/PD integration and modeling of marbofloxacin in sheep. Res Vet Sci 88:34–41
   Web of Science ®Google Scholar
• Toutain PL, Lees P. (2004). Integration and modeling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. J Vet Pharmacol Ther 27:467–77
   PubMed Web of Science ®Google Scholar
• Van Hoovels L, Vankeerberghen A, Boel A, et al. (2006). First case of Staphylococcus pseudintermedius infection in a human. J Clin Microbiol 44:4609–12
   PubMed Web of Science ®Google Scholar
• Walker RD. (2000). The use of fluoroquinolones for companion animal antimicrobial therapy. Aust Vet J 78:84–90
   PubMed Web of Science ®Google Scholar
• Waxman S, Rodríguez C, González F, et al. (2001). Pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in adult goats. J Vet Pharmacol Ther 4:375–8
   Google Scholar
• Yoo JW, Lee KJ, Lee SY, et al. (2010). Antibiotic resistance profiles of Staphylococcus pseudintermedius isolates from canine patients in Korea. J Microbiol Biotechnol 20:1764–8
   PubMed Web of Science ®Google Scholar